Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-12
2007-06-12
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S227800, C514S236800, C514S326000, C514S374000, C514S378000, C540S603000, C544S060000, C544S137000, C546S208000, C548S235000, C548S247000
Reexamination Certificate
active
10512986
ABSTRACT:
The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
REFERENCES:
patent: 2641601 (1953-06-01), Rachlin et al.
patent: 2858318 (1958-10-01), Graf et al.
patent: 3708598 (1973-01-01), Griot
patent: 6034106 (2000-03-01), Feng et al.
patent: WO 00/06556 (2000-10-01), None
patent: WO 02/10146 (2002-02-01), None
patent: WO 02/32897 (2002-04-01), None
STN International, HCAPLUS Database, Columbus, OH, Accession No. 2000:98534.
Gallagher, et al., “Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase,” Bioorganic & Medicinal Chemistry, Elsevier Science Ltd, GB, vol. 5, No. 1, pp. 49-64; XP002094123 (1997).
Diwu, et al, “Fluorescent molecular probes II. The synthesis, spectral properties and use of dluorescent solvatochromic dapoxyl dyes,” Photochemistry and Photobiology, Oxford, GB, vol. 66, No. 4, pp. 424-431; XP009003751 (1997).
Ni, et al., “Synthesis and Luminescent Properties of 2-Phenyl-5-{4′2-(6-substituent-2H-benz′De isoquinoline-1,3(2H)-dione-2-yl)polymethano-amino-{phenyl-1,3,4-oxadiazole,” Chemistry Letters, Chemical Society of Japan, Tokyo, JP, No. 1, pp. 101-102; XP000671632 (1997).
De Laszlo S E, et al., “Pyrroles and other heterocycles as inhibitors of P38 kinase,” Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 8, No. 19, pp. 2689-2694; XP004139602 (1998).
McLay, et al, “The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthrititc efficacy,” Bioorganic & Medicinal Chemistry Letters, vol. 9, pp. 537-554; XP002248371 (2001.
Meyer, et al., “Water-binding solid scintillators: synthesis, emission properties, and tests in 3H and 14C counting,” Chem. Eur. J., vol. 6, No. 15, pp. 2809-2817; XP002248372 (2000).
Database Crossfire Beilstein Online, Beilstein Institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE, Database accession No. BRN 567765; XP002248373; Abstract & Shevchenko, et al, Sov. Prog. Chem, vol. 44, No. 8, pp. 58-61 (1978).
Database Crossfire Beilstein Online, Beilstein Institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE, Database accession No. BRN 6936668; XP002248374; Abstract & Litak, et al, J. Heterocycl. Chem., vol. 31, No. 2, pp. 457-480 (1994).
Database Crossfire Beilstein Online, Beilstein Institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE, Database accession No. BRN 1507962, 1502375, 1512417; XP002248375; Abstract & Iyer & Gopalachari: Indian J. Chem., vol. 11, p. 1260 (1973).
Goff, et al., “The Preparation of 2,4-Disubstituted Thiazoles on Solid Support,” Tetrahedron Letters, Elsevier Science Publishers, Amsterdam, NL, vol. 40, No. 3, pp. 423-426; XP004151347 (1999).
Penning, et al, Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-′5-(4-Methylphenyl)-3-(trifluoromethyl)-1 H-pyrazole-1-yl benzene-sulfonamide (SC-58635, Celecoxib), Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 40, pp. 1347-1365; XP002114833 (1997).
Ammenn Jochen
Gillig James Ronald
Heinz Lawrence Joseph
Hipskind Philip Arthur
Kinnick Michael Dean
Eli Lilly and Company
Freistein Andrew B.
Ginah Francis O.
Saeed Kamal A.
LandOfFree
Multicyclic compounds for use as melanin concentrating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multicyclic compounds for use as melanin concentrating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multicyclic compounds for use as melanin concentrating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3828999